Erbitux® (cetuximab)
Erbitux®. (cetuximab). May 2017. Merck Oncology. PROGNOSIS. The active substance in Erbitux cetuximab
Erbitux Factsheet
Les Direct Healthcare Professional Communications (DHPC) sont
(exons 2 3 et 4 de KRAS et NRAS) avant le traitement par Erbitux® (cetuximab). Madame
DHPC Erbitux FR Website
27009437 - Merck Amsterdam cetuximab Erbitux MCRC FR
21 mai 2007 geneesmiddel cetuximab (Erbitux®) bij de behandeling van gemetastaseerd colorectaalcarcinoom. Voor de bepaling van de therapeutische waarde ...
Cetuximab (Erbitux) bij gemetastaseerd colorectaalcarcinoom
Erbitux INN-cetuximab
cetuximab. The combination of Erbitux with oxaliplatin-containing chemotherapy is contraindicated for patients with mutant RAS metastatic colorectal cancer
erbitux epar product information en
Package leaflet: Information for the user - Erbitux 5 mg/mL solution
Cetuximab binds to the epidermal growth factor receptor (EGFR) an antigen on the surface of certain cancer cells. EGFR activates proteins called RAS. RAS
Erbitux Packshot
Merck Press Release
2 mars 2020 ERBITUX® in combination with platinum-based therapy with ... company today announced that ERBITUX® (cetuximab) has been granted approval.
Erbitux L Approval In China SCCHN EN FINAL
Erbitux INN-cetuximab
conocidas a cetuximab. La combinación de Erbitux y quimioterapia basada en oxaliplatino está contraindicada en pacientes con cáncer colorrectal metastásico
ERBITUX FT
Erbitux INN-cetuximab
Chaque mL de solution pour perfusion contient 5 mg de cetuximab. Erbitux est indiqué dans le traitement des patients présentant un cancer colorectal ...
erbitux epar product information fr
ERBITUX (cetuximab)
patients with squamous cell carcinoma of the head and neck receiving ERBITUX with radiation therapy or with a cetuximab product with platinum-based therapy
s lbl
Merck Strengthens Presence as Leading Oncology Company by
13 févr. 2015 transfer full responsibility for the promotion of Erbitux® (cetuximab) to Merck in Japan as of May 1 2015. "Expanding our oncology presence ...
Erbitux Japan EN